Related Experiment Video
Updated: Jun 4, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
Glycemic Management and Individualized Diabetes Care in Dialysis-Dependent Kidney Failure
Klara R Klein1, Ildiko Lingvay2,3, Katherine R Tuttle4,5
1Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, NC.
Diabetes Care
|December 18, 2024
Summary
Diabetes care for dialysis patients is complex. Optimal glycemic targets and medication effectiveness require more research, emphasizing personalized, holistic care for better outcomes.
Area of Science:
- Nephrology
- Endocrinology
- Public Health
Background:
- Over 60% of chronic kidney failure patients on dialysis in the U.S. have diabetes.
- Diabetes is linked to worse survival rates in dialysis patients.
- Kidney failure complicates diabetes management, making general guidelines unreliable.
Purpose of the Study:
- To review the challenges and evidence gaps in managing diabetes for dialysis patients.
- To highlight the need for personalized diabetes care in this population.
- To identify areas for future research on glycemic targets and therapies.
Main Methods:
- Review of existing observational data and clinical trial limitations.
- Analysis of factors complicating glycemic control and medication use in dialysis.
- Synthesis of current knowledge on HbA1c targets and diabetes therapies.
Main Results:
- Optimal glycemic targets for dialysis patients are not prospectively established.
- Both low and high HbA1c levels are associated with mortality in this group.
- Limited data exist on the safety and effectiveness of glucose-lowering medications.
Conclusions:
- Current evidence is insufficient to extend general diabetes guidelines to dialysis patients.
- Person-centered, holistic diabetes care is crucial, integrating individual needs and proven treatments.
- Further research is essential to apply new advances in diabetes management for dialysis patients.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
234
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
01:27Dialysis
261
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
261
01:22Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
01:22Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
01:16Insulin: Dosing Regimen and Adverse Effects
142
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142
01:11Renal Failure: Dose Adjustments
63
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
63